Observational studyHaematologica2026

REALiTEC: a multi-country observational retrospective study of teclistamab in patients with relapsed/refractory multiple myeloma outside of clinical trials.

Katarina Uttervall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.